Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300079
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,966
Award facts
- Contract value 100% obligated
- $4,966.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Walkersville, MD 21793, USA
- Legislative mandates
-
- Economy Act FAR subpart 17.5
Award details come from SAM.gov/FPDS.
About this award
Lonza Walkersville, Inc., a foreign-owned manufacturer of biological materials and laboratory equipment, received a Blanket Purchase Agreement (BPA) call award valued at $4,966.32 from the Department of Health and Human Services (HHS) Office of Logistics and Acquisition Operations. The contract, awarded on April 11, 2017, with an ultimate completion date of April 18, 2017, falls under the Drugs and Biologicals category and utilizes firm fixed-price pricing. The work will be performed at Lonza Walkersville's facility in Walkersville, Maryland. This award represents a task order placed against Lonza Walkersville's existing single-award BPA with HHS valued at $10 million and valid through December 31, 2025. No set-aside designation was used in this procurement.
Lonza Walkersville, Inc. specializes in providing high-precision biological research products and services to federal agencies, particularly the National Institutes of Health (NIH) and its various institutes, including support for critical research in cancer studies, infectious diseases, and regenerative medicine. As a subsidiary of the global Lonza Group and a registered SAM.gov vendor since 2002, the company has established itself as a key supplier of cell culture media, specialized cell lines, transfection devices, and advanced scientific instrumentation to the federal research community. Through its BPA vehicle, Lonza Walkersville streamlines the procurement of biological materials, blood products, laboratory supplies, and medical and scientific equipment for multiple NIH research centers.
Quick answers
Who was awarded contract HHSN26300079?
HHSN26300079 was awarded to Lonza Walkersville, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on April 11, 2017.
How much is contract HHSN26300079 worth?
The government has obligated $4,966 on HHSN26300079.
Is contract HHSN26300079 an order under another contract?
Yes. HHSN26300079 is a BPA call under HHSN263201600052B, a blanket purchase agreement.
Was contract HHSN26300079 competed?
The extent of competition for HHSN26300079 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award